The STEP 1 trial for weight loss: a step change in treating obesity?

Nat Med. 2021 Apr;27(4):589-590. doi: 10.1038/s41591-021-01319-4.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adult
  • Glucagon-Like Peptides
  • Humans
  • Obesity / therapy
  • Overweight*
  • Weight Loss*

Substances

  • semaglutide
  • Glucagon-Like Peptides